Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Sarcoma 1Other solid neoplasm 1Gynecologic 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Mesothelioma 17Mesothelioma, Malignant 15Solid Tumor 10Carcinoma, Non-Small-Cell Lung 8Advanced Solid Tumors 8Melanoma 6Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Advanced Solid Tumor 5Solid Tumors 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Ovarian Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Merkel Cell 3Advanced or Metastatic Solid Tumors 3Turcot syndrome 2Stomach Neoplasms 2Neoplasm Metastasis 2Malignant Solid Tumor 2Lung Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Cholangiocarcinoma 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Granulocyte Colony-Stimulating Factor 5Filgrastim 5Thiotepa 3Cyclophosphamide 3sargramostim 2Topotecan 2Melphalan 2Ifosfamide 2Etoposide 2Carboplatin 2Busulfan 2racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1entinostat 1cixutumumab 1atezolizumab 1alvocidib 1Thrombopoietin 1Thalidomide 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Mesna 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × Nivolumab × Other solid neoplasm × Clear all
NCT04040231 2025-05-13

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
10 enrolled
GenitourinaryOther solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡